article thumbnail

Daewoong Pharmaceutical revolutionizes drug development with AI-Driven DAISY system

Digital Health Global

Daewoong Pharmaceutical , a prominent player in the South Korean pharmaceutical industry, has unveiled its groundbreaking drug development system, Daewoong AI System (DAISY). About DAISY DAISY represents the culmination of over 40 years of research and development by Daewoong Pharmaceutical.

article thumbnail

Deliberate AI Announces its Depression and Anxiety Model, AI-COA™, is the First AI/ML Initiative to Be Accepted into the FDA’s ISTAND Pilot Program to Advance Drug Development

Digital Health Global

NEW YORK–(BUSINESS WIRE)– Deliberate AI , a digital health technology company that delivers precision measurement of mental health through AI, today announced its inclusion in the U.S. Food and Drug Administration (FDA) Innovative Science and Technology Approaches for New Drugs (ISTAND) Pilot Program.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Tris Pharma Launches Digital Health Business to Develop and Commercialize Digital Products for ADHD

Digital Health Global

– Tris Digital Health enters into licensing agreement with Braingaze to develop and commercialize first-in-class, AI-enhanced technology that offers healthcare professionals an objective tool to improve accuracy of ADHD diagnosis – – Tris will conduct U.S. and Canada – MONMOUTH JUNCTION, N.J.–(BUSINESS

article thumbnail

Digital Health Technologies in Clinical Trials

Digital Health Global

Digital Health Technologies ( DHTs ) have revolutionized the landscape of clinical trials, particularly in neurology research, by enabling the collection of real-world data outside traditional clinical settings. Additionally, another of Healthware’s DHT services for clinical trials is CliniScout ePRO.

article thumbnail

Biofourmis announces major agreements with top pharmaceutical companies

Digital Health Global

Biofourmis , a global digital health and clinical trial solutions leader, announces four key partnerships with top pharmaceutical firms. Beyond digital biomarker and endpoint expertise, pharmaceutical partners are leveraging Biofourmis to streamline study timelines through its Digital Clinical Trials solution.

article thumbnail

Koneksa Announces New Multi-Domain Model for Functional Status Assessment Enabled by Digital Health Technologies

Digital Health Global

The paper, titled: “A Proposed Multi-Domain Digital Model for Capturing Functional Status and Health-Related Quality of Life in Oncology,” highlights the importance of collecting continuous 24/7 functional status measures digitally to enable better clinical decisions and outcomes assessment. Chief Medical Officer, Koneksa.

article thumbnail

Digital Healthcare Transformation: Improving Patient Experience and Outcomes

Digital Health Global

Patient experience has become a primary focus in our industry, and the digital transformation has provided new ways to enhance it. Enhancing outcomes for patients with the implementation of digital technologies, such as artificial intelligence (AI) and big data analysis, empowers healthcare professionals to make better-informed decisions.